Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Human immunodeficiency virus (HIV) II infection category B1
0.060 AlteredExpression disease BEFREE The severity of CIN correlated directly with the intensities of p-53 (Spearman Rho = 0.19; P = 0.05) and Ki-67 immunostaining (Spearman Rho = 0.46, P < 0.001) and with apoptosis and Bcl-2 expression (chi-square for trend = 10.6 and 3.91 , P < 0.001 and P = 0.048, respectively).After adjustment, by logistic regression analysis, for the potential confounding effect of severity of CIN and Human Papillomavirus (HPV) infection, apoptosis was five times more common in cervical biopsies of HIV seropositive compared to HIV seronegative patients (27 out of 73 as compared to 4 out of 36, adjusted Odds Ratio = 5.0; 95% confidence intervals = 1.56-16.33, P = 0.007). 15581953 2004
Human immunodeficiency virus (HIV) II infection category B1
0.060 Biomarker disease BEFREE Interleukin-7 and infection itself by human immunodeficiency virus 1 favor virus persistence in mature CD4(+)CD8(-)CD3(+) thymocytes through sustained induction of Bcl-2. 11568004 2001
Human immunodeficiency virus (HIV) II infection category B1
0.060 Biomarker disease BEFREE This work aims at characterizing the interplay between human immunodeficiency virus type 1 (HIV-1) and the antiapoptotic cellular protein Bcl-2 responsible for a persistent infection in lymphoblastoid T (J.Jhan) or monocytic (U937) cells. 9811703 1998
Human immunodeficiency virus (HIV) II infection category B1
0.060 Biomarker disease BEFREE Conversely, BCL-6(-)/LMP-1(+)/BCL-2(+) PCNSL are restricted to HIV-infected hosts and are represented by lymphomas with immunoblastic features. 9680371 1998
Human immunodeficiency virus (HIV) II infection category B1
0.060 GeneticVariation disease BEFREE They were monoclonal B-cell proliferations, as evaluated by immunoglobulin (Ig) gene rearrangement analyses, and had rearrangement of the c-myc oncogene in 68% of cases but not the bcl-2 gene, in contrast to a previous study on non-HIV-associated BLL. 9850023 1998
Human immunodeficiency virus (HIV) II infection category B1
0.060 AlteredExpression disease BEFREE The human immunodeficiency virus type-1 (HIV-1) Tat protein and Bcl-2 gene expression. 9031086 1996